XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2018     21,743,498        
Beginning balance at Dec. 31, 2018 $ 1,425,224   $ 217 $ 1,306,653 $ 118,322   $ 32
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]              
Stock-based compensation 12,116     12,033 83    
Exercise of stock options, net (in shares)     103,364        
Exercise of stock options, net (1,773)   $ 2 (1,775)      
Issuance of restricted stock, net (in shares)     117,947        
Issuance of restricted stock, net (7,472)   $ 1 (7,473)      
Common stock dividends (46,724)       (46,724)    
Foreign currency translation adjustments 0            
Unrealized gains (losses) on marketable securities, net of tax 201           201
Net income 81,138       81,138    
Ending balance (in shares) at Dec. 31, 2019     21,964,809        
Ending balance at Dec. 31, 2019 $ 1,462,710 $ (3,311) $ 220 1,309,438 152,819 $ (3,311) 233
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]              
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2016-13 [Member]            
Issuance of common stock in public offering (in shares)     2,185,000        
Issuance of common stock in public offering $ 220,248   $ 22 220,226      
Stock-based compensation 14,610     14,593 17    
Exercise of stock options, net (in shares)     20,522        
Exercise of stock options, net 1,244     1,244      
Issuance of restricted stock, net (in shares)     250,377        
Issuance of restricted stock, net (25,845)   $ 2 (25,847)      
Repurchase of common stock (in shares)     (1,769)        
Repurchase of common stock (247)     (105) (142)    
Common stock dividends (56,005)       (56,005)    
Foreign currency translation adjustments 48,068           48,068
Unrealized gains (losses) on marketable securities, net of tax 579           579
Net income 86,268       86,268    
Ending balance (in shares) at Dec. 31, 2020     24,418,939        
Ending balance at Dec. 31, 2020 1,748,319   $ 244 1,519,549 179,646   48,880
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]              
Stock-based compensation 18,149     18,094 55    
Exercise of stock options, net (in shares)     1,632        
Exercise of stock options, net 113     113      
Issuance of restricted stock, net (in shares)     248,496        
Issuance of restricted stock, net (2,994)   $ 3 (2,997)      
Repurchase of common stock (in shares)     (76,969)        
Repurchase of common stock (5,905)   $ (1) (4,790) (1,114)    
Common stock dividends (59,102)       (59,102)    
Foreign currency translation adjustments (39,392)           (39,392)
Unrealized gains (losses) on marketable securities, net of tax (285)           (285)
Net income 55,087       55,087    
Ending balance (in shares) at Dec. 31, 2021     24,592,098        
Ending balance at Dec. 31, 2021 $ 1,713,990   $ 246 $ 1,529,969 $ 174,572   $ 9,203